I share your optimism, but until cancer is proven in clinical trials (which I think it will), I am hesitant to incorporate such figures into my calculations as it becomes extremely large. If cancer is successful, then $30+ a share is very possible, but putting a time on share appreciation is difficult....and anything above $10 sounds crazy to me when we are currently at $.52 (that's a 20 bagger).
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.